SEARCH

SEARCH BY CITATION

References

  • ABASSI, Z., BURNETT, J., GRUSHKA, E., HOFFMAN, A., HARAMATI, A. & WINAVER, J. (1991). Atrial natriuretic peptide and renal cGMP in rats with experimental heart failure. Am. J. Physiol., 261, R858R864.
  • ABASSI, Z.A., POWELL, J., GOLOMB, E. & KEISER, H. (1992a). Renal and systemic effects of urodilatin in rats with high-output heart failure. Am. J. Physiol., 262, F615F621.
  • ABASSI, Z.A., TATE, J., GOLOMB, E. & KEISER, H. (1992b). Role of neutral endopeptidase in the metabolism of endothelin. Hypertension, 20, 8995.
  • ABOUCHACRA, S., SKORECKI, K., BAINES, A., ZINMAN, B. & LOGAN, A. (1992). ANF resistance in essential hypertension. J. Am. Soc. Nephrol., 39, 530 (Abstract).
  • DICKINSON, K.E.J., TYMIAK, A.A., COHEN, R.B., LIU, E.C.K., WEBB, M.L. & HEDBERG, A. (1991). Vascular A10 cell membranes contain an endothelin metabolizing neutral endopeptidase. Biochem. Biophys. Res. Commun., 176, 423430.
  • FAGNY, C., MICHEL, A., LEONARD, I., BERKENBOOM, G., FONTAINE, J. & DESCHODT-LANCKMAN, M. (1991). In vitro degradation of endothelin-1 by endopeptidase 24.11 (enkephalinase). Peptides, 12, 773778.
  • GARDINER, S., KEMP, P.A. & BENNETT, T. (1992). Effects of the neutral endopeptidase inhibitor, SQ 28,603, on regional haemodynamic responses to atrial natriuretic peptide or pro-endothelin-1 [1–38] in conscious rats. Br. J. Pharmacol., 106, 180186.
  • GORMAN, C., GIESS, D., SCHOFIELD, P., KADU-FONG, H. & MALFROY, B. (1989). Expression of enzymatically active enkephalinase (neutral endopeptidase) in mammalian cells. J. Cell Biochem., 39, 277284.
  • HECKER, M., KAW, S. & WALSH, D.T. (1992). Determination of endothelin-converting enzyme activity by high-performance liquid chromatography-on-line radioactivity flow monitoring. J. Chromatogr., 574, 344348.
  • IKEGAWA, R., MATSUMURA, Y., TAKAODA, M. & MORIMOTO, S. (1990a). Evidence for pepstatin-sensitive convertion of porcine big endothelin-1 to endothelin-1 by the endothelial cell extract. Biochem. Biophys. Res. Commun., 167, 860866.
  • IKEGAWA, R., MATSUMURA, Y., TSUKAHARA, Y., TAKAOKA, M. & MORIMOTO, S. (1990b). Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme. Biochem. Biophys. Res. Commun., 171, 669675.
  • KAW, S., HECKER, M. & VANE, J. (1992). The two-step conversion of big endothelin 1 to endothelin 1 and degradation of endothelin 1 by subcellular fractions from human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. U.S.A., 89, 68866890.
  • KUNDU, G. & WILSON, I. (1992). Identification of endothelin converting enzyme in bovine lung membranes using a new fluorogenic substrate. Life Sci., 50, 965970.
  • LLORENS-CORTES, C., HUANG, H., VICART, P., GASC, J.M., PAULIN, D. & CORVOL, P. (1992). Identification and characterization of neutral endopeptidase in endothelial cells from venous or arterial origins. J. Biol. Chem., 267, 1401214018.
  • MALFROY, B., KUANG, W.-J., SEEBURG, P., MASON, A. & SCHOFIELD, P. (1988). Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase). FEBS Lett., 229, 206210.
  • MATSUMURA, Y., IKEGAWA, R., HISAKI, K., TSUKAHARA, Y., TAKAOKA, M. & MORIMOTO, S. (1991). Conversion of big endothelin-1 to endothelin-1 by phosphoramidon-sensitive metalloproteinase derived from aortic endothelial cells. J. Cardiovasc. Pharmacol., 17 (Suppl. 7), S65S67.
  • MATSUMURA, Y., IKEGAWA, R., TAKAOKA, M. & MORIMOTO, S. (1990a). Conversion of porcine big endothelin by an extract from the porcine aortic endothelial cells. Biochem. Biophys. Res. Commun., 167, 203210.
  • MATSUMUAR, Y., IKEGAWA, R., TSUKAHARA, Y., TAKAOKA, M. & MORIMOTO, S. (1990b). Phosphoramidon-sensitive endothelin-converting enzyme in vascular endothelial cells converts big endothelin-1 and big endothelin-3 to their mature form. FEBS Lett., 272, 166170.
  • McMAHON, E., PALOMO, M., MOORE, W., McDANOLD, T. & STERN, M. (1991). Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1–39) in vivo and conversion of big endothelin-1-(1–39) to endothelin-1-(1–21) in vitro. Proc. Natl. Acad. Sci. U.S.A., 88, 703707.
  • OLINS, G., SPEAR, K., SIEGEL, N., REINHARD, E. & ZURCHER-NEELY, H. (1987). Atrial peptide inactivation by rabbit kidney brush border membranes. Eur. J. Biochem., 170, 431434.
  • OKADA, K., MIYAZAKI, Y., TAKADA, J., MATSUYAMA, K., YAMAKI, T. & YANO, M. (1990). Conversion of big endothelin-1 by membrane-bound metalloendopeptidase in cultured bovine endothelial cells. Biochem. Biophys. Res. Commun., 171, 11921198.
  • OKADA, K., TAKADA, J., ARAI, Y., MATSUYAMA, K. & YANO, M. (1991). Importance of the C-terminal region of big endothelin-1 for specific conversion by phosphoramidon-sensitive endothelin converting enzyme. Biochem. Biophys. Res. Commun., 180, 10191023.
  • POLLOCK, D. & OPGENORTH, T. (1991). Evidence for metalloprotease involvement in the in vivo effects of big endothelin 1. Am. J. Physiol., 261, R257R263.
  • PONS, F., TOUVAY, C., LAGENTE, V., MENCIA-HUERTA, J.M. & BRAQUET, P. (1992). Involvement of a phosphoramidon-sensitive endopeptidase in the processing of big endothelin-1 in the guinea-pig. Eur. J. Pharmacol., 217, 6570.
  • SAWAMURA, T., KIMURA, S., SHINMI, O., SUGITA, Y., MASASHI, Y., GOTO, K. & MASAKI, T. (1990a). Purification and characterization of putative endothelin converting enzyme in bovine adrenal medulla: evidence for cathepsin D-like enzyme. Biochem. Biophys. Res. Commun., 168, 12301236.
  • SAWAMURA, T., SHINMI, O., KISHI, N., SUGITA, Y., YANAGISAWA, M., GOTO, K., MASAKI, T. & KIMURA, S. (1990b). Analysis of big endothelin-1 digestion by cathespin D. Biochem. Biophys. Res. Commun., 172, 883889.
  • SEYMOUR, A., NORMAN, J., ASSAD, M., TENNELL, S., LITTLE, D., KRATUNIS, V. & ROGERS, L. (1991). Antihypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase. J. Cardiovasc. Pharmacol., 17, 296304.
  • SOKOLOVSKY, M., GALRON, R., KLOOG, Y., BDOLAH, A., INDIG, F.E., BLUMBERG, S. & FLEMINGER, G. (1990). Endothelins are more sensitive than sarafotoxin to neutral endopeptidase: possible physiological significance. Proc. Natl. Acad. Sci. U.S.A., 87, 47024706.
  • SYBERTZ, E. (1990). Drugs inhibiting the metabolism and inactivation of atrial natriuretic factor: pharmacological actions and therapeutic implications. Cardiovasc. Drug Rev., 8, 7182.
  • TAKADA, J., HATA, M., OKADA, K., MMATSUYAMA, K. & YANO, M. (1992). Biochemical properties of endothelin converting enzyme in renal epithelial cell lines. Biochem. Biophys. Res. Commun., 182, 13831388.
  • TAKAOKA, M., HUKUMOR, Y., SHIRAGAMI, K., IKEGAWA, R., MATSUMURA, Y. & MORIMOTO, S. (1990). Proteolytic processing of porcine big endothelin-1 catalyzed by cathepsin D. Biochem. Biophys. Res. Commun., 173, 12181223.
  • TURNER, A. (1987). Neuropeptides and their Peptidases. ed. TURNER, A. pp. 183201.Chichester, Sussex: Horwood.
  • VIJAYARAGHAVAN, J., SCICLI, A., CARRETERO, O., SLAUGHTER, C., MOOMAW, C. & HERSH, L. (1990). The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J. Biol. Chem., 265, 1415014155.
  • WU-WONG, J., BUDZIK, G., DEVINE, E. & OPGENORTH, T. (1990). Characterization of endothelin converting enzyme in rat lung. Biochem. Biophys. Res. Commun., 171, 12911296.
  • WYPIJ, D., NICHOLS, J., NOVAK, P., STACY, I., BERMAN, J. & WISEMAN, J. (1992). Role of mast cell chymase in the extracellular processing of big-endothelin-1 to endothelin-1 in the perfused rat lung. Biochem. Pharmacol., 43, 845853.
  • YAMAGUCHI, T., KIDO, H. & KATUNUMA, N. (1992). A membrane-bound metallo-endopeptidase from rat kidney: characteristics of its hydrolysis of peptide hormones and neuropeptides. Eur. J. Biochem., 204, 547552.
  • YANAGISAWA, M., KURIHARA, H., KIMURA, S., TOMOBE, Y., KOBAYASHI, M., MITSUI, Y., YAZAKI, Y., GOTO, K. & MASAKI, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411415.